CYP2C19 loss-of-function alleles are not associated with clinical outcome of clopidogrel therapy in patients treated with newer-generation drug-eluting stents
about
CYP2C19 genotype and adverse cardiovascular outcomes after stent implantation in clopidogrel-treated Asian populations: A systematic review and meta-analysis.Effects of genetic variants on platelet reactivity and one-year clinical outcomes after percutaneous coronary intervention: A prospective multicentre registry study.
P2860
CYP2C19 loss-of-function alleles are not associated with clinical outcome of clopidogrel therapy in patients treated with newer-generation drug-eluting stents
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
CYP2C19 loss-of-function allel ...... generation drug-eluting stents
@en
CYP2C19 loss-of-function allel ...... eneration drug-eluting stents.
@nl
type
label
CYP2C19 loss-of-function allel ...... generation drug-eluting stents
@en
CYP2C19 loss-of-function allel ...... eneration drug-eluting stents.
@nl
prefLabel
CYP2C19 loss-of-function allel ...... generation drug-eluting stents
@en
CYP2C19 loss-of-function allel ...... eneration drug-eluting stents.
@nl
P2093
P2860
P1433
P1476
CYP2C19 loss-of-function allel ...... generation drug-eluting stents
@en
P2093
Chul-Soo Park
Ho-Sook Kim
Hun-Jun Park
Ik Jun Choi
Jae-Gook Shin
Ki-Bae Seung
Kiyuk Chang
Mahn-Won Park
Pum-Joon Kim
Sung Ho Her
P2860
P356
10.1097/MD.0000000000004049
P407
P577
2016-06-01T00:00:00Z